Many
snake venoms are known for their antithrombotic activity. They contain components that specifically target different platelet-activating receptors such as the
collagen-binding
integrin α2β1 and the
von Willebrand factor receptor GPIb. In a search for an α2β1
integrin-blocking component from the
venom of the habu snake (Trimeresurus flavoviridis), we employed two independent purification protocols. First, we used the
integrin α2A domain, a major
collagen-binding domain, as bait for affinity purification of an α2β1
integrin-binding toxin from the crude
venom. Second, in parallel, we used classical
protein separation protocols and tested for α2β1
integrin-inhibiting capabilities by ELISA. Using both approaches, we identified
flavocetin-A as an inhibitor of α2β1
integrin. Hitherto,
flavocetin-A has been reported as a GPIb inhibitor. However,
flavocetin-A inhibited
collagen-induced platelet aggregation even after GPIb was blocked with other inhibitors. Moreover,
flavocetin-A antagonized α2β1
integrin-mediated adhesion and migration of HT1080 human
fibrosarcoma cells, which lack any GPIb, on
collagen.
Protein chemical analyses proved that
flavocetin-A binds to α2β1
integrin and its α2A domain with high affinity and in a cooperative manner, which most likely is due to its quaternary structure. Kinetic measurements confirmed the formation of a strong complex between
integrin and
flavocetin-A, which dissociates very slowly. This study proves that
flavocetin-A, which has long been known as a GPIb inhibitor, efficiently targets α2β1
integrin and thus blocks
collagen-induced platelet activation. Moreover, our findings suggest that the separation of GPIb- and α2β1
integrin-blocking members within the
C-type lectin-related
protein family is less strict than previously assumed.